Fairmount Funds Management LLC 13D and 13G filings for Axsome Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 3:46 pm Purchase |
2023-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
Fairmount Funds Management LLC | 2,360,077 4.900% |
15,097 (+0.64%) |
Filing |
| 2023-07-07 4:00 pm Purchase |
2023-06-28 | 13G | Axsome Therapeutics, Inc. AXSM |
Fairmount Funds Management LLC | 2,344,980 5.000% |
333,333 (+16.57%) |
Filing |
| 2023-02-14 3:45 pm Sale |
2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
Fairmount Funds Management LLC | 2,011,647 4.600% |
-155,000 (-7.15%) |
Filing |
| 2022-10-25 9:09 pm Purchase |
2022-09-16 | 13G | Axsome Therapeutics, Inc. AXSM |
Fairmount Funds Management LLC | 2,166,647 5.400% |
2,166,647 (New Position) |
Filing |